Company Directory / research
Public · OTC:RLFTFFor profitresearchGeneva, Switzerland
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
- Founded
- 2013 13 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $98M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
13 years old.
Reach
Website ranked #4,147,355 in the world for traffic, about 2k visits a month.
What it does
BiotechnologyClinical TrialsPharmaceutical
Funding, as listed
$98M currency not stated
- Rounds6
- LatestPost ipo equity, Aug 2024
- Investors2, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Relief Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Relief Therapeutics
- Type
- For profit
- Status
- Public · OTC:RLFTF
- Founded
- 2013
- Founders
- Gaël Hédou, Michel Dreano, Yves Sagot
- Industry
- research
- Categories
- Biotechnology, Clinical Trials, Pharmaceutical
Where
- City
- Geneva
- Country
- Switzerland
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #4,147,355
- Monthly web visits
- 2,478
Funding, as listed
- Total
- 98,166,171 (currency not stated)
- Rounds
- 6
- Latest round
- Post ipo equity
- Latest round date
- Aug 2024
- Investors
- 2
- Lead investors
- 2
- Stock listing
- OTC:RLFTF
- Listing status
- public
Corporate family
- Acquisitions made
- 3
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Relief Therapeutics may be growing as it has renewed a CHF 50 million share subscription facility, which indicates the company's ability to secure significant funding to support its operations and potential expansion. This financial mechanism provides the company with access to capital that can be used for various growth-related activities such as research and development, clinical trials, or marketing. The renewal of such a substantial facility suggests that investors have confidence in the company's prospects, which is a positive sign for its financial health and growth trajectory.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Switzerland.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.